Pseudodeficiency alleles
Pseudodeficiency alleles are genetic variants that can cause a false positive result in newborn screening tests for certain metabolic disorders. These alleles do not cause disease symptoms, but they can interfere with the biochemical assays used in newborn screening, leading to a false diagnosis of a metabolic disorder.
Overview
Pseudodeficiency alleles are genetic variants that can cause a false positive result in newborn screening tests for certain metabolic disorders. These alleles do not cause disease symptoms, but they can interfere with the biochemical assays used in newborn screening, leading to a false diagnosis of a metabolic disorder.
Characteristics
Pseudodeficiency alleles are typically found in genes that encode enzymes involved in the metabolism of certain substances. These alleles can cause the enzyme to function less efficiently, leading to an accumulation of the substance in the body. However, this accumulation is not sufficient to cause disease symptoms.
Impact on Newborn Screening
Newborn screening tests are designed to detect metabolic disorders by measuring the levels of certain substances in the body. If a pseudodeficiency allele is present, the test may indicate a high level of the substance, leading to a false positive result. This can cause unnecessary stress and medical intervention for the family.
Examples
One example of a pseudodeficiency allele is found in the gene for the enzyme arylsulfatase A. This allele can cause a false positive result in newborn screening tests for metachromatic leukodystrophy, a severe metabolic disorder.
Another example is found in the gene for the enzyme galactocerebrosidase. This allele can cause a false positive result in newborn screening tests for Krabbe disease, another severe metabolic disorder.
Conclusion
While pseudodeficiency alleles can cause false positive results in newborn screening tests, they do not cause disease symptoms. Therefore, it is important for healthcare providers to confirm a positive screening result with additional diagnostic testing to avoid unnecessary medical intervention.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


